Home
Companies
Catalysts
Deep Dives
Pulmonary arterial hypertension
CVRM · 1 drugs · 2 indications
Competitive Landscape (1 drugs)
Drug
Company
Mechanism
Modality
Route
Stage
Winrevair
MRK
ActRIIA-Fc fusion
Fc-fusion
SC
APPROVED
Indications (2)
PAH
Winrevair
APPROVED
PH-LHD
Winrevair
PHASE3
Upcoming Catalysts
Winrevair - PAH - Label Expansion Data
CLINICAL
MRK
2026
Data from Supabase · Updated 2026-03-24